Autopsy report · NCT02508311
Albuterol to Improve Respiratory Strength in SCI
Cause of deathStaffing, sites or logistics, also drug or device supply
“Our ability to test subjects with tetraplegia in this interventional study was interrupted by the COVID-19 pandemic. Our research pharmacist also informed us that oral albuterol is no longer being manufactured.”
Life of this trial
- Registered 11 months before it started.
- Ran for about 6 years 9 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- VA Office of Research and Development
- Sponsor type
- US federal agency
- Conditions
- Spinal Cord Injury; Respiratory Muscle Weakness
- Interventions
- Oral Albuterol Extended Release; Placebo
- Participants
- 1
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.